Baseline Modern Medical Management in the BEST-CLI Trial.

[1]  Manesh R. Patel,et al.  Understanding Study Drug Discontinuation Through EUCLID , 2022, Frontiers in cardiovascular medicine.

[2]  V. Huckell,et al.  Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease. , 2022, The Canadian journal of cardiology.

[3]  R. Eckel,et al.  National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020 , 2022, Journal of the American Heart Association.

[4]  P. Chu,et al.  Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a retrospective multi-institutional study. , 2021, Diabetes research and clinical practice.

[5]  J. Golledge,et al.  A meta-analysis of randomised controlled trials evaluating the efficacy of smoking cessation interventions in people with peripheral artery disease. , 2021, Journal of vascular surgery.

[6]  Manesh R. Patel,et al.  Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease. , 2021, Journal of the American College of Cardiology.

[7]  N. Hamburg,et al.  Racial and Ethnic Disparities in Peripheral Artery Disease , 2021, Circulation research.

[8]  M. Creager,et al.  Contemporary Medical Management of Peripheral Artery Disease , 2021, Circulation research.

[9]  David W. Johnson,et al.  Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials , 2021, BMJ.

[10]  J. Schensul,et al.  Black-white Disparities in Social and Behavioral Determinants of Health Index and Their Associations with Self-rated Health and Functional Limitations in Older Adults. , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[11]  M. Creager,et al.  Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Dorairaj Prabhakaran,et al.  2020 International Society of Hypertension global hypertension practice guidelines. , 2020, Journal of hypertension.

[13]  Khendi T White Solaru,et al.  Evidence-Based Medical Management of Peripheral Artery Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[14]  John V. White,et al.  Global vascular guidelines on the management of chronic limb-threatening ischemia. , 2019, Journal of vascular surgery.

[15]  K. Rosenfield,et al.  The BEST‐CLI trial is nearing the finish line and promises to be worth the wait , 2019, Journal of vascular surgery.

[16]  L. Tarnow,et al.  The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial , 2018, Diabetes Care.

[17]  6. Glycemic Targets: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[18]  E. Amsterdam,et al.  Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease. , 2017, The American journal of cardiology.

[19]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[20]  K. Mahaffey,et al.  Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Artery Disease , 2017, The New England journal of medicine.

[21]  S. Assmann,et al.  Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial , 2016, Journal of the American Heart Association.

[22]  K. Berger,et al.  Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. , 2015, European heart journal.

[23]  M Hassan Murad,et al.  Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. , 2015, Journal of vascular surgery.

[24]  Biykem Bozkurt,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[25]  H. Bang,et al.  Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease , 2014, Journal of the American Heart Association.

[26]  J. Beckman,et al.  Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004 , 2011, Circulation.

[27]  J. Bittl,et al.  Concomitant peripheral arterial disease and coronary artery disease: therapeutic opportunities. , 2004, Circulation.

[28]  K. Eagle,et al.  Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. , 2004, Journal of vascular surgery.

[29]  Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy , 1994, BMJ.

[30]  M. Caulfield,et al.  Hypertension , 1931, The Lancet.

[31]  A Ross Naylor,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.

[32]  M. Prins,et al.  Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. , 2003, The Cochrane database of systematic reviews.